A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.
Cea
Michele
M
Cirmena
Gabriella
G
Garuti
Anna
A
Rocco
Ilaria
I
Palermo
Claudia
C
Cagnetta
Antonia
A
Moran
Eva
E
Colombo
Nicoletta
N
Grasso
Raffaella
R
Fugazza
Giuseppina
G
Gobbi
Marco
M
Nencioni
Alessio
A
Ballestrero
Alberto
A
Patrone
Franco
F
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000069439:Dasatinib; D005260:Female; D016313:Genes, abl; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib